Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Bismuth Containing Quadruple Therapy and Clarithromycin Susceptibility-based Tailored Therapy for Helicobacter Pylori First-line Eradication

NCT03361267 is registered in ClinicalTrials.gov with Inha University Hospital as lead sponsor.

NCT NCT03361267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03361267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Bismuth Containing Quadruple Therapy and Clarithromycin Susceptibility-based Tailored Therapy for Helicobacter Pylori First-line Eradication
Lead sponsor
Inha University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 30, 2017
Completion date
June 28, 2018
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotics, compliance, patient, drug resistance, helicobacter pylori infection